Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide StudyKatharina Brück, Richard P Meijer, Joost L Boormans, et al.International Journal of Radiation Oncology, Biology, Physics|July 4, 2025
Health-Related Quality of Life in Patients Treated for Nonmetastatic Muscle-Invasive Bladder Cancer: Radical Cystectomy Versus Bladder-Preserving TherapyKatharina Brück, Vera Atema, Annemarie M Leliveld, et al.European Urology|March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular CancerJoost M Blok, Harmke J Groot, Eline H Huele, et al.BMJ Open|March 7, 2023
EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trialEmine Akdemir, Maike G Sweegers, Alina Vrieling, et al.BJU International|September 2, 2025
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancerMichiel Vlaming, Wouter Koole, R Jeroen A van Moorselaar, et al.European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.Pageof 9